Die News bedeutet das der Weg für die Zulassung frei ist .. Meine Empfehlung lautet alles unter 2$ wegkaufen denn IPCI ist mit 17 Mio$ Marktkapitalisierung gnadenlos unterbewertet . Viel Glück
Intellipharmaceutics Announces Settlement for its Generic Version of Focalin XR(R)
TORONTO, March 11, 2010 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. ( Nasdaq :IPCI) (TSX:I) today announced that Novartis Pharmaceuticals Corporation and Celgene Corporation have settled their patent suit in the U.S. District Court for the District of New Jersey, and Elan Pharma International Ltd. has settled its patent suit in the U.S. District Court for the District of Delaware, with Intellipharmaceutics Corp., a wholly-owned subsidiary of Intellipharmaceutics International, and its licensee Par Pharmaceutical, Inc. over a generic version of the Attention Deficit Hyperactivity Disorder drug Focalin XR® (dexmethylphenidate hydrochloride). The terms of the settlements are confidential and remain subject to regulatory and court approval. |